Showing results (41-50 of 265) with videos related to
Sort By:
Pageof 27
Current Diabetes Reports|March 20, 2003
Molecular etiologies of MODY and other early-onset forms of diabetesDavid Q Shih, Markus StoffelWorld Journal of Gastroenterology|November 11, 2011
Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel diseaseKara Bradford, David Q ShihEuropean Journal of Immunology|May 6, 2003
CD2 mediates activation of the IFN-gamma intronic STAT binding region in mucosal T cellsRivkah Gonsky, Richard L Deem, Howard A Young, et al.World Journal of Gastroenterology|June 15, 2006
Immunogenetic phenotypes in inflammatory bowel diseaseMarla-C Dubinsky, Kent Taylor, Stephan-R Targan, et al.Gastroenterology|July 19, 2011
Cathelicidin signaling via the Toll-like receptor protects against colitis in miceHon Wai Koon, David Q Shih, Jeremy Chen, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2017
Myeloid ATG16L1 Facilitates Host-Bacteria Interactions in Maintaining Intestinal HomeostasisHong Zhang, Libo Zheng, Dermot P B McGovern, et al.Inflammatory Bowel Diseases|May 19, 2015
Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel DiseaseSeper Dezfoli, Henry A Horton, Nattapaun Thepyasuwan, et al.Gut|July 5, 2012
The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in miceTressia C Hing, Samantha Ho, David Q Shih, et al.The Gastroenterology Report|May 6, 2011
All Roads Lead to Rome: Update on Rome III Criteria and New Treatment OptionsDavid Q Shih, Lola Y KwanNature Reviews. Drug Discovery|August 2, 2008
Certolizumab pegolGil Y Melmed, Stephan R Targan, Uma Yasothan, et al.Pageof 27